Skip to content
PeptideAgent

Clinics in Oregon

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Oregon law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Oregon at a glance

Pharmacy regulator
Oregon Board of Pharmacy
503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Oregon

No verified clinics serving Oregon are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Oregon

Yes. An Oregon resident can obtain FDA approved peptides such as semaglutide and tirzepatide from any prescriber licensed by the Oregon Medical Board or the relevant Oregon licensing board, including through telemedicine under Oregon Medical Board rules in Oregon Administrative Rules chapter 847, division 25, and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy registered with the Oregon Board of Pharmacy as an in-state or out-of-state drug outlet. The Board of Pharmacy regulates compounding through OAR chapter 855, division 183 (adopted June 17, 2026), which incorporates USP standards and follows the FDA 503A bulks framework rather than a separate Oregon list. [1] [2] [3] [4] [5] [6] [7] [8] [11]

Compounded GLP-1 access in Oregon

Telehealth GLP-1 patients should confirm the dispensing pharmacy appears in the Board of Pharmacy license lookup. [1] [9]

Research use only sellers in Oregon

ORS chapter 689 restricts dispensing of prescription drugs to registered pharmacies and licensed practitioners, and a seller of "research use only" injectable peptides to Oregon consumers is not a registered drug outlet. Oregon's Unlawful Trade Practices Act (ORS 646.608) also reaches misleading health claims made to consumers. [5] [10]

How to check a clinic in Oregon

  1. Confirm the prescribing clinician's license with the Oregon medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Oregon Board of Pharmacy license lookup. [1] [5] [6] [7] [8]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Oregon. [5] [10]

Common questions in Oregon

Can I get a GLP-1 prescription in Oregon through telemedicine?

Yes. Oregon Medical Board rules allow an Oregon-licensed physician (including a physician holding an OAR 847-025 license for practice across state lines) to establish a relationship and prescribe through telemedicine when the evaluation meets the in-person standard of care. Semaglutide and tirzepatide are not controlled substances, so no separate in-person requirement applies. [2] [3]

Can an out-of-state telehealth doctor treat me in Oregon?

Only if the physician holds a full Oregon license or an Oregon license for the practice of medicine across state lines under OAR 847-025. Oregon is not a member of the Interstate Medical Licensure Compact, so a compact license does not cover Oregon patients. Look the prescriber up in the Oregon Medical Board license search before paying. [2] [3] [11]

All peptide legal questions for Oregon

Sources

  1. [1]Oregon Board of Pharmacy
  2. [2]Oregon Medical Board (license search and board policies)
  3. [3]Oregon Administrative Rules chapter 847, division 25, Licensure to Practice Medicine Across State Lines (Oregon Medical Board)
  4. [4]ORS 743A.058, Telemedicine coverage and definitions
  5. [5]ORS chapter 689, Pharmacists; Drug Outlets; Drug Sales
  6. [6]Oregon Administrative Rule 855-041-1060, Non-Resident Pharmacies
  7. [7]Oregon Administrative Rules chapter 855, division 183, Drug Compounding (Oregon Board of Pharmacy, effective June 17, 2026)
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts
  11. [11]Interstate Medical Licensure Compact Commission: participating states